Active substances
Lactic acid + Salicylic acid
- SFDA 2
- NHS prices 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| AVOMACK | 16.7,16.7 % (W/W),% (W/W) | Cutaneous solution · Topical | 1 Bottle | SAR 18.00 | Generic · Prescription | Middle East Pharmaceutical Industries Co Ltd Avalon Pharma | Valid |
| AVOMACK | 16.7,16.7 % (W/W),% (W/W) | Cutaneous solution · Topical | 1 Bottle | SAR 24.00 | Generic · Prescription | Middle East Pharmaceutical Industries Co Ltd Avalon Pharma | Valid |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Salicylic acid 12% / Lactic acid 4% gel | £3.26 | 8 gram | 1 Oct 2026 |
| NHS Drug Tariff | Salicylic acid 16.7% / Lactic acid 15% paint | £3.40 | 15 ml | 1 Oct 2026 |
| NHS Drug Tariff | Salicylic acid 16.7% / Lactic acid 16.7% paint | £2.26 | 10 ml | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.